Top Markets
Coin of the day
Rebus Holdings, Inc. Rebus Holdings, Inc.

Rebus Holdings, Inc.

RBSH
Rang in Aktien #42217
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for... Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy. The corporation was established in 2003 and maintains its headquarters in Westlake Village, California.
Aktienkurs
$0.0001
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$3.21K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Rebus Holdings, Inc. (RBSH)

Kategorie

Kursverlauf für Rebus Holdings, Inc. (RBSH)
Höchster Schlusskurs: $0.00 am 2026-08-01

Niedrigster Schlusskurs: $4.22M am 2009-11-01
Kursverlauf der Aktie von Rebus Holdings, Inc. von 2009 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 -4.55%
2024 -98.16%
2023 -39.81%
2022 -78.02%
2021 -92.91%
2020 -96.74%
2019 -93.08%
2018 -87.91%
2017 -96.90%
2016 -82.98%
2015 -64.73%
2014 -46.26%
2013 -46.40%
2012 18.83%
2011 1.07%
2010 -3.78%
2009 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR